SARS-CoV-2 structural features may explain limited neutralizing-antibody responses

被引:43
作者
Bachmann, Martin F. [1 ,2 ,3 ]
Mohsen, Mona O. [2 ,3 ]
Zha, Lisha [1 ]
Vogel, Monique [1 ]
Speiser, Daniel E. [4 ,5 ]
机构
[1] Anhui Agr Univ, Int Immunol Ctr, Hefei, Peoples R China
[2] Univ Hosp Bern, Dept Rheumatol Immunol & Allergol, Bern, Switzerland
[3] Univ Bern, Dept BioMed Res, Bern, Switzerland
[4] Univ Hosp, Lausanne, Switzerland
[5] Univ Lausanne, Lausanne, Switzerland
基金
瑞士国家科学基金会;
关键词
CORONAVIRUS; IMMUNITY; CELL; ANTIGEN; IMMUNOGENICITY; INFECTION;
D O I
10.1038/s41541-020-00264-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Neutralizing antibody responses of SARS-CoV-2-infected patients may be low and of short duration. We propose here that coronaviruses employ a structural strategy to avoid strong and enduring antibody responses. Other viruses induce optimal and long-lived neutralizing antibody responses, thanks to 20 or more repetitive, rigid antigenic epitopes, spaced by 5-10nm, present on the viral surface. Such arrays of repetitive and highly organized structures are recognized by the immune system as pathogen-associated structural patterns (PASPs), which are characteristic for pathogen surfaces. In contrast, coronaviruses are large particles with long spikes (S protein) embedded in a fluid membrane. Therefore, the neutralizing epitopes (which are on the S protein) are loosely "floating" and widely spaced by an average of about 25nm. Consequently, recruitment of complement is poor and stimulation of B cells remains suboptimal, offering an explanation for the inefficient and short-lived neutralizing antibody responses.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
    Seow, Jeffrey
    Graham, Carl
    Merrick, Blair
    Acors, Sam
    Pickering, Suzanne
    Steel, Kathryn J. A.
    Hemmings, Oliver
    O'Byrne, Aoife
    Kouphou, Neophytos
    Galao, Rui Pedro
    Betancor, Gilberto
    Wilson, Harry D.
    Signell, Adrian W.
    Winstone, Helena
    Kerridge, Claire
    Huettner, Isabella
    Jimenez-Guardeno, Jose M.
    Lista, Maria Jose
    Temperton, Nigel
    Snell, Luke B.
    Bisnauthsing, Karen
    Moore, Amelia
    Green, Adrian
    Martinez, Lauren
    Stokes, Brielle
    Honey, Johanna
    Izquierdo-Barras, Alba
    Arbane, Gill
    Patel, Amita
    Tan, Mark Kia Ik
    O'Connell, Lorcan
    O'Hara, Geraldine
    MacMahon, Eithne
    Douthwaite, Sam
    Nebbia, Gaia
    Batra, Rahul
    Martinez-Nunez, Rocio
    Shankar-Hari, Manu
    Edgeworth, Jonathan D.
    Neil, Stuart J. D.
    Malim, Michael H.
    Doores, Katie J.
    NATURE MICROBIOLOGY, 2020, 5 (12) : 1598 - +
  • [22] Protective neutralizing epitopes in SARS-CoV-2
    Liu, Hejun
    Wilson, Ian A.
    IMMUNOLOGICAL REVIEWS, 2022, 310 (01) : 76 - 92
  • [23] Review of therapeutic mechanisms and applications based on SARS-CoV-2 neutralizing antibodies
    Liu, Mingtao
    Gan, Hui
    Liang, Zhiman
    Liu, Li
    Liu, Qiwen
    Mai, Yiyin
    Chen, Huihuang
    Lei, Baoying
    Yu, Shangwei
    Chen, Huihui
    Zheng, Peiyan
    Sun, Baoqing
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [24] Neutralizing antibodies for SARS-CoV-2 infection
    Berenguer, Juan
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2022, 35 : 16 - 19
  • [25] Lymphocyte Subpopulations Associated with Neutralizing Antibody Levels of SARS-CoV-2 for COVID-19 Vaccination
    Huang, Wan-Ting
    Weng, Shao-Wen
    Tzeng, Hong-Tai
    Yen, Feng-Chun
    Chiang, Yu-Shao
    You, Huey-Ling
    VACCINES, 2022, 10 (09)
  • [26] Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome
    Roltgen, Katharina
    Powell, Abigail E.
    Wirz, Oliver F.
    Stevens, Bryan A.
    Hogan, Catherine A.
    Najeeb, Javaria
    Hunter, Molly
    Wang, Hannah
    Sahoo, Malaya K.
    Huang, ChunHong
    Yamamoto, Fumiko
    Manohar, Monali
    Manalac, Justin
    Otrelo-Cardoso, Ana R.
    Pham, Tho D.
    Rustagi, Arjun
    Rogers, Angela J.
    Shah, Nigam H.
    Blish, Catherine A.
    Cochran, Jennifer R.
    Jardetzky, Theodore S.
    Zehnder, James L.
    Wang, Taia T.
    Narasimhan, Balasubramanian
    Gombar, Saurabh
    Tibshirani, Robert
    Nadeau, Kari C.
    Kim, Peter S.
    Pinsky, Benjamin A.
    Boyd, Scott D.
    SCIENCE IMMUNOLOGY, 2020, 5 (54)
  • [27] Long-term persistence of SARS-CoV-2 neutralizing antibody responses after infection and estimates of the duration of protection
    Lau, Eric H. Y.
    Hui, David S. C.
    Tsang, Owen T. Y.
    Chan, Wai-Hung
    Kwan, Mike Y. W.
    Chiu, Susan S.
    Cheng, Samuel M. S.
    Ko, Ronald Lw
    Li, John K. C.
    Chaothai, Sara
    Tsang, Chi H.
    Poon, Leo L. M.
    Peiris, Malik
    ECLINICALMEDICINE, 2021, 41
  • [28] An Overview of the Conventional and Novel Methods Employed for SARS-CoV-2 Neutralizing Antibody Measurement
    Rocha, Vinicius Pinto Costa
    Quadros, Helenita Costa
    Fernandes, Antonio Marcio Santana
    Goncalves, Luana Pereira
    Badaro, Roberto Jose da Silva
    Soares, Milena Botelho Pereira
    Machado, Bruna Aparecida Souza
    VIRUSES-BASEL, 2023, 15 (07):
  • [29] A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
    Shi, Rui
    Shan, Chao
    Duan, Xiaomin
    Chen, Zhihai
    Liu, Peipei
    Song, Jinwen
    Song, Tao
    Bi, Xiaoshan
    Han, Chao
    Wu, Lianao
    Gao, Ge
    Hu, Xue
    Zhang, Yanan
    Tong, Zhou
    Huang, Weijin
    Liu, William Jun
    Wu, Guizhen
    Zhang, Bo
    Wang, Lan
    Qi, Jianxun
    Feng, Hui
    Wang, Fu-Sheng
    Wang, Qihui
    Gao, George Fu
    Yuan, Zhiming
    Yan, Jinghua
    NATURE, 2020, 584 (7819) : 120 - +
  • [30] Neutralizing Antibody Responses to SARS-CoV-2 in Korean Patients Who Have Recovered from COVID-19
    Kim, Yoon-Jung
    Bae, Joon-Yong
    Bae, Sohyun
    Hwang, Soyoon
    Kwon, Ki Tae
    Chang, Hyun-Ha
    Lee, Won Kee
    Cui, Chunguang
    Lee, Gee Eun
    Kim, Shin-Woo
    Park, Man-Seong
    YONSEI MEDICAL JOURNAL, 2021, 62 (07) : 584 - 592